Literature DB >> 7853583

A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment.

R Colombo1, A Lev, L F Da Pozzo, M Freschi, G Gallus, P Rigatti.   

Abstract

For some time hyperthermia, alone or in combination with radiotherapy or chemotherapy, has proved to be a promising method for treating several kinds of solid tumors. After intensive laboratory investigations a new device, based on a microwave source delivering local bladder hyperthermia together with intravesical mitomycin C chemotherapy has been clinically tested as a neoadjuvant approach in 44 patients suffering from superficial cancer of the bladder. The combined approach was administered on an outpatient basis without major complications and with acceptable local toxicity. Endoscopic and histological evaluations proved that combined local hyperthermia and chemotherapy can induce necrosis of transitional tumors. The overall response rate was 90.8%, with 70.4% complete and 20.4% partial, leaving 4 patients (9.2%) nonrespondent. Clinical and histological evaluations have confirmed the feasibility and safety of this combined treatment. Further multicentric studies have been initiated.

Entities:  

Mesh:

Year:  1995        PMID: 7853583

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

Review 1.  Adjuvant methods to improve results of local bladder irrigations by chemotherapy for NMIBC.

Authors:  Yuval Freifeld; Yoram Dekel; Avi Stein
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

2.  Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma.

Authors:  Yu Yuan; Kung-Shan Cheng; Oana I Craciunescu; Paul R Stauffer; Paolo F Maccarini; Kavitha Arunachalam; Zeljko Vujaskovic; Mark W Dewhirst; Shiva K Das
Journal:  Med Phys       Date:  2012-03       Impact factor: 4.071

3.  Effect of selective inhibition of aquaporin 1 on chemotherapy sensitivity of J82 human bladder cancer cells.

Authors:  Xuefeng Zhang; Yun Chen; Liming Dong; Benkang Shi
Journal:  Oncol Lett       Date:  2018-01-04       Impact factor: 2.967

Review 4.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

5.  Physicochemical modulation of skin barrier by microwave for transdermal drug delivery.

Authors:  Tin Wui Wong; Anuar Nor Khaizan
Journal:  Pharm Res       Date:  2012-08-14       Impact factor: 4.200

6.  Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.

Authors:  R Paroni; A Salonia; A Lev; L F Da Pozzo; G Cighetti; F Montorsi; P Rigatti; R Colombo
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

7.  Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I-II study.

Authors:  Francesco Soria; Paola Milla; Chiara Fiorito; Francesca Pisano; Filippo Sogni; Massimiliano Di Marco; Vincenzo Pagliarulo; Franco Dosio; Paolo Gontero
Journal:  World J Urol       Date:  2015-05-31       Impact factor: 4.226

8.  Combined intravesical hyperthermia and mitomycin chemotherapy: a preliminary in vivo study.

Authors:  Lea Rath-Wolfson; Boaz Moskovitz; Yoram Dekel; Valentina Kugel; Rumelia Koren
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

Review 9.  Intravesical treatments of bladder cancer: review.

Authors:  Zancong Shen; Tong Shen; M Guillaume Wientjes; Michael A O'Donnell; Jessie L-S Au
Journal:  Pharm Res       Date:  2008-03-28       Impact factor: 4.200

Review 10.  Overview of bladder heating technology: matching capabilities with clinical requirements.

Authors:  Paul R Stauffer; Gerard C van Rhoon
Journal:  Int J Hyperthermia       Date:  2016-03-04       Impact factor: 3.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.